EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Innate Immune Gene Polymorphisms and COVID-19 Prognosis

Evangelos Bakaros iD, Ioanna Voulgaridi iD, Vassiliki Paliatsa, Nikolaos Gatselis iD, Georgios Germanidis iD, Evangelia Asvestopoulou, Stamatia Alexiou, Elli Botsfari, Vasiliki Lygoura, Olga Tsachouridou, Iordanis Mimtsoudis, Maria Tseroni und 8 weitere

Viruses · 2023

DOI: 10.3390/v15091784 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Evangelos Bakaros und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology & Histocompatibility, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: standard budget provided by the Research Committee of the University of Thessaly.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 is characterized by a heterogeneous clinical presentation and prognosis. Risk factors contributing to the development of severe disease include old age and the presence of comorbidities. However, the genetic background of the host has also been recognized as an important determinant of disease prognosis. Considering the pivotal role of innate immunity in the control of SARS-CoV-2 infection, we analyzed the possible contribution of several innate immune gene polymorphisms (including TLR2-rs5743708, TLR4-rs4986790, TLR4-rs4986791, CD14-rs2569190, CARD8-rs1834481, IL18-rs2043211, and CD40-rs1883832) in disease severity and prognosis. A total of 249 individuals were enrolled and further divided into five (5) groups, according to the clinical progression scale provided by the World Health Organization (WHO) (asymptomatic, mild, moderate, severe, and critical). We identified that elderly patients with obesity and/or diabetes mellitus were more susceptible to developing pneumonia and respiratory distress syndrome after SARS-CoV-2 infection, while the IL18-rs1834481 polymorphism was an independent risk factor for developing pneumonia. Moreover, individuals carrying either the TLR2-rs5743708 or the TLR4-rs4986791 polymorphisms exhibited a 3.6- and 2.5-fold increased probability for developing pneumonia and a more severe disease, respectively. Our data support the notion that the host’s genetic background can significantly affect COVID-19 clinical phenotype, also suggesting that the IL18-rs1834481, TLR2-rs5743708, and TLR4-rs4986791 polymorphisms may be used as molecular predictors of COVID-19 clinical phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AgedHumansInterleukin-18Toll-Like Receptor 2Toll-Like Receptor 4SARS-CoV-2PrognosisImmunity, InnatePolymorphism, GeneticRisk FactorsNeoplasm ProteinsCARD Signaling Adaptor Proteins

Stichwörter der Autor:innen

CARD8CD14CD40COVID-19IL18TLR2TLR4innate immunitypolymorphismprognosis

Substanzen

Interleukin-18Toll-Like Receptor 2Toll-Like Receptor 4CARD8 protein, humanNeoplasm ProteinsCARD Signaling Adaptor Proteins

Autor:innen und Institutionen

  • Department of Immunology & Histocompatibility, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece.
  • Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.
  • Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, Full Member of the European Reference Network on Hepatological Diseases (ERN RARE-LI…
  • First Internal Medicine Department, Infectious Diseases Division, AHEPA Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
  • National Public Health Organization, 15123 Athens, Greece.

ORCID-Profile: Evangelos Bakaros, Ioanna Voulgaridi, Nikolaos Gatselis, Georgios Germanidis, Styliani Sarrou, Katerina Dadouli, Christos Hadjichristodoulou, Matthaios Speletas

Förderung

  • standard budget provided by the Research Committee of the University of Thessaly

Zitieren

APA

Bakaros, E., Voulgaridi, I., Paliatsa, V., Gatselis, N., Germanidis, G., Asvestopoulou, E., Alexiou, S., Botsfari, E., Lygoura, V., Tsachouridou, O., Mimtsoudis, I., Tseroni, M., Sarrou, S., Mouchtouri, V. A., Dadouli, K., Kalala, F., Metallidis, S., Dalekos, G., Hadjichristodoulou, C., & Speletas, M. (2023). Innate Immune Gene Polymorphisms and COVID-19 Prognosis. Viruses. https://doi.org/10.3390/v15091784

Vancouver

Bakaros E, Voulgaridi I, Paliatsa V, Gatselis N, Germanidis G, Asvestopoulou E, et al. Innate Immune Gene Polymorphisms and COVID-19 Prognosis. Viruses. 2023. doi:10.3390/v15091784

BibTeX
@article{Bakaros2023,
  author = {Bakaros, Evangelos and Voulgaridi, Ioanna and Paliatsa, Vassiliki and Gatselis, Nikolaos and Germanidis, Georgios and Asvestopoulou, Evangelia and Alexiou, Stamatia and Botsfari, Elli and Lygoura, Vasiliki and Tsachouridou, Olga and Mimtsoudis, Iordanis and Tseroni, Maria and Sarrou, Styliani and Mouchtouri, Varvara A and Dadouli, Katerina and Kalala, Fani and Metallidis, Simeon and Dalekos, George and Hadjichristodoulou, Christos and Speletas, Matthaios},
  title = {Innate Immune Gene Polymorphisms and COVID-19 Prognosis},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15091784}
}
Kostenlos starten →